Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07634640 · ClinicalTrials.gov registry record · Early Phase 1
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
A Early Phase 1 study, sponsored by University of Florida.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 70
- Enrollment target
NCT07634640 is a Early Phase 1 study that is actively recruiting participants, run by University of Florida. The registered enrollment target is 70 participants.
The verdict
NCT07634640, a Early Phase 1 study, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
Interventions
- DRUG Ferumoxytol infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-11-03 |
| Est. Completion | 2027-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07634640
The ClinicalTrials.gov registry entry for NCT07634640 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferumoxytol infusion is the first listed.
NCT07634640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07634640 about?
NCT07634640 is a clinical study titled "Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction". Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
What is the current status of trial NCT07634640?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 70 participants. The study started on 2023-11-03. Estimated completion is 2027-05-31.
What interventions are being tested in trial NCT07634640?
The interventions under investigation include: Ferumoxytol infusion (DRUG).
Who is sponsoring clinical trial NCT07634640?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.